Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Future Microbiol ; 12: 1219-1237, 2017 10.
Article in English | MEDLINE | ID: mdl-28972415

ABSTRACT

The borrelial resurge demonstrates that Borrelia burgdorferi is a persistent health problem. This spirochete is responsible for a global public health concern called Lyme disease. B. burgdorferi faces diverse environmental conditions of its vector and host during its life cycle. To circumvent the host immune system is a prominent feature of B. burgdorferi. To date, numerous studies have reported on the various mechanisms used by this pathogen to evade the host defense mechanisms. This current review attempts to consolidate this information to describe the immunological and molecular methods used by B. burgdorferi for its survival.


Subject(s)
Borrelia burgdorferi/immunology , Host-Pathogen Interactions/immunology , Immune Evasion , Lyme Disease/immunology , Antigen-Antibody Complex , Antigenic Variation , Antigens, Bacterial , Bacterial Proteins/metabolism , Borrelia burgdorferi/genetics , Borrelia burgdorferi/pathogenicity , Borrelia burgdorferi/physiology , Cytokines , Gene Expression Regulation, Bacterial , Gene Transfer, Horizontal , Recombination, Genetic , Spirochaetales/immunology
2.
J Gen Virol ; 90(Pt 8): 2050-2060, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19339478

ABSTRACT

Dysfunction of the endoplasmic reticulum associated protein degradation/proteasome system is believed to contribute to the initiation or aggravation of neurodegenerative disorders associated with protein misfolding, and there is some evidence to suggest that proteasome dysfunctions might be implicated in prion disease. This study investigated the effect of proteasome inhibitors on the biogenesis of both the cellular (PrP(C)) and abnormal (PrP(Sc)) forms of prion protein in CAD neuronal cells, a newly introduced prion cell system. In uninfected cells, proteasome impairment altered the intracellular distribution of PrP(C), leading to a strong accumulation in the Golgi apparatus. Moreover, a detergent-insoluble and weakly protease-resistant PrP species of 26 kDa, termed PrP(26K), accumulated in the cells, whether they were prion-infected or not. However, no evidence was found that, in infected cells, this PrP(26K) species converts into the highly proteinase K-resistant PrP(Sc). In the infected cultures, proteasome inhibition caused an increased intracellular aggregation of PrP(Sc) that was deposited into large aggresomes. These findings strengthen the view that, in neuronal cells expressing wild-type PrP(C) from the natural promoter, proteasomal impairment may affect both the process of PrP(C) biosynthesis and the subcellular sites of PrP(Sc) accumulation, despite the fact that these two effects could essentially be disconnected.


Subject(s)
Cytosol/chemistry , Prions/metabolism , Proteasome Inhibitors , Animals , Cells, Cultured , Golgi Apparatus/chemistry , Mice , Neurons/chemistry , Neurons/drug effects , Protein Denaturation
SELECTION OF CITATIONS
SEARCH DETAIL
...